rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-1-24
|
pubmed:abstractText |
Long-term oral treatment of patients with acute coronary syndromes and type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors is associated with positive, though ambiguous changes in the left-ventricular structure and function. These changes should be the reason for choosing optimal therapy ensuring better prognosis in this patient population.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-4888
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
138
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
301-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15665929-Adrenergic beta-Antagonists,
pubmed-meshheading:15665929-Adult,
pubmed-meshheading:15665929-Aged,
pubmed-meshheading:15665929-Angina, Unstable,
pubmed-meshheading:15665929-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:15665929-Bisoprolol,
pubmed-meshheading:15665929-Diabetes Mellitus, Type 2,
pubmed-meshheading:15665929-Drug Therapy, Combination,
pubmed-meshheading:15665929-Enalapril,
pubmed-meshheading:15665929-Female,
pubmed-meshheading:15665929-Heart,
pubmed-meshheading:15665929-Hemodynamics,
pubmed-meshheading:15665929-Humans,
pubmed-meshheading:15665929-Male,
pubmed-meshheading:15665929-Middle Aged,
pubmed-meshheading:15665929-Myocardial Infarction,
pubmed-meshheading:15665929-Prognosis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis.
|
pubmed:affiliation |
Kuban State Medical Academy, Krasnodar.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|